期刊文献+

89例细支气管肺泡癌手术治疗

下载PDF
导出
摘要 目的:探讨细支气管肺泡癌(bronchioloalveolar carcinoma,BAC)外科治疗效果。方法:收集1990年1月至2003年12月收治并经病理证实的89例BAC患者的资料,分析BAC的临床特点、外科治疗方法及不同TNM分期外科治疗的效果。结果:全组行根治性手术85例,姑息切除3例,开胸探查术1例;术后1年、3年、5年生存率分别为75.5%、50.6%、42.7%;按UICC肺癌国际分期,Ⅰ期、Ⅱ期、Ⅲ期BAC患者之间生存率差异有统计学意义(P<0.05)。结论:BAC是一种特殊类型肺腺癌,有着独特的临床病理表现、影像学特点及预后。肺叶切除加区域淋巴结清扫术是治疗BAC常用的手术方法。早期诊断、早期治疗是提高BAC生存率的关键。
机构地区 山西省肿瘤医院
出处 《山西职工医学院学报》 CAS 2011年第1期34-35,共2页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献9

  • 1Read WL,Page NC,Tierney RM,et al. The Epidemiology of Ronchioloalveolar Carcinoma over the Past Two Decades : Analysis of the SEER Database [ J ]. Lung Cancer,2004,45 ( 2 ) : 137-142.
  • 2Jemal A, Murray T, Ward E, et al. Cancer Statistics, 2005 [ J ]. CA Cancer J Clin ,2005,55 : 10-30.
  • 3Brambilla E, Travis WD, Colby TV, et al. The New World Health Organization Classification of Lung Tumours [ J ]. Eur Respir J ,2001,18 (6) :1059-1068.
  • 4Greco RJ, Steiner RM, Goldman S ,et al. Bronchioloalveolar Cell Carcinoma of the Lung[ J]. Ann Thorac Surg, 1986,41:652-656.
  • 5刘群群,陈丽华.弥漫性细支气管肺泡癌30例诊断及误诊分析[J].临床肺科杂志,2005,10(5):687-688. 被引量:8
  • 6吴一龙,蒋国樑,陆舜,周清华,张力,无.支气管肺泡细胞癌之中国共识[J].循证医学,2006,6(4):227-230. 被引量:28
  • 7Hsu CP, Chen CY, Hsu NY. Bronchioloalveolar Carcinoma [ J ]. J Tho rac Cardiovasc Surg, 1995,110 ( 2 ) :374-381.
  • 8Miller DL, Rowland CM, Deschamps C, et al. Surgical Treatment of Non-Small Cell Lung Cancer 1 cm or Less in Diameter[ J]. Ann Thorac Surg,2002,73 : 1545-1550.
  • 9Breathnach OS, Kwiat DJ, Finkel DM,et al. Bronchioloal Veolarcarei non of the Lung: Recurrences and Survival in Patients with Stage I Disease[ J]. Thorac Cardiovesc Surg,2001,121 (1) :42-47.

二级参考文献17

  • 1Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours[J]. Eur Respir J, 2001,18:1059-1068.
  • 2Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors [J]. Semin in Roentgenol, 2005,40(2) : 90-97.
  • 3Kris MG, Sandler A, Miller V, et al. Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase Ⅱ trial in patients with bronchioloalveolar cacinoma (BAC) [J].Proc Am Soc Clin Oncol, 2004,23:631S.
  • 4Jackman DM, Chirieac LR, Janne PA. Bronchioloalveolar carcinoma: A review of the epidemiology, pathology, and treatment [J]. Semin Respir Crit Care Med, 2005,26 (3):342-352.
  • 5Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma [J ]. Ann Thorac Surg, 2002,74(5) : 1640-1646.
  • 6Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival [J]. Eur Cardiothorac Surg, 2003,23 : 818-823.
  • 7Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved [J]. J Thorac Cardiovasc Surg, 2003,126: 1597-1601.
  • 8West HL, Crowley J J, Vance RB, et al. Advanced brocnhioloalveolar carcinoma: A phase Ⅱ trial of paclitaxel by 96-hour infusion (SWOG 9714) [J]. Ann Oncol : in press.
  • 9West H, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126 [J]. J Clin Oncol, 2006,24(12):1807-1813.
  • 10Lee DH, Han JY, Lee HG, et al. Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers [J]. Clin Cancer Res, 2005,11 (8) :3032-3037.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部